Entero Healthcare Solutions Limited (NSE:ENTERO)
India · Delayed Price · Currency is INR 1,151.50
-11.40 (-0.98%)
At close: Feb 10, 2026
NSE:ENTERO Revenue
Entero Healthcare Solutions had revenue of 15.71B INR in the quarter ending September 30, 2025, with 20.78% growth. This brings the company's revenue in the last twelve months to 56.73B, up 28.21% year-over-year. In the fiscal year ending March 31, 2025, Entero Healthcare Solutions had annual revenue of 50.96B with 29.92% growth.
Revenue (ttm)
56.73B
Revenue Growth
+28.21%
P/S Ratio
0.88
Revenue / Employee
13.80M
Employees
4,111
Market Cap
50.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50.96B | 11.73B | 29.92% |
| Mar 31, 2024 | 39.22B | 6.22B | 18.85% |
| Mar 31, 2023 | 33.00B | 7.78B | 30.85% |
| Mar 31, 2022 | 25.22B | 7.49B | 42.24% |
| Mar 31, 2021 | 17.73B | 4.23B | 31.38% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 232.65B |
| Divi's Laboratories | 100.29B |
| Akums Drugs and Pharmaceuticals | 41.10B |
| Innova Captab | 14.97B |
| Yatharth Hospital & Trauma Care Services | 10.95B |
| Supriya Lifescience | 7.15B |
Entero Healthcare Solutions News
- 3 months ago - Entero Healthcare Solutions Ltd (NSE:ENTERO) Q2 2026 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 3 months ago - Q2 2026 Entero Healthcare Solutions Ltd Earnings Call Transcript - GuruFocus